MedPath

Clinical Feasibility of a Conformal Ultrasound Blood Pressure Sensor

Completed
Conditions
Medical Device
Feasibility Study
Interventions
Device: sphygmomanometer
Device: Arterial Line
Registration Number
NCT05909605
Lead Sponsor
University of California, San Diego
Brief Summary

Blood pressure (BP) monitoring is essential for managing cardiovascular diseases. Arterial line (A-line), the clinical gold standard for BP monitoring, is too invasive for routine measurements. The sphygmomanometer, on the other hand, is non-invasive but captures only discrete values. The recently introduced conformal ultrasound sensor offers non-invasive and continuous monitoring of BP, which can potentially improve the quality of patient care, but its accuracy has yet to be thoroughly validated. Here the investigators are working to validate the accuracy of a redesigned ultrasound sensor with enhanced reliability in BP measurements at-home and in clinics even under different interventions.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Are able to provide informed consent
  • Have at least one arm
Exclusion Criteria
  • Active cardiac arrhythmias
  • Any other unstable, active medical condition (i.e., cardiac arrythmia, uncontrolled diabetes, active heart failure, active liver failure)
  • Currently pregnant (this will be confirmed with a urine pregnancy test in women of childbearing potential)
  • Any large movements of the arms (e.g., chorea, dyskinesias, ballism), that in the investigators' opinion, would make it difficult to measure blood pressure using a standard blood pressure cuff
  • Any active skin infection or wound on the arm that would interfere with the devices used to measure blood pressure
  • Diagnosis of dementia

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Ultrasound blood pressure sensorArterial Line-
Ultrasound blood pressure sensorsphygmomanometer-
Primary Outcome Measures
NameTimeMethod
Device comparison to standard monitoring (Sphygmomanometer)4 years

Clinical feasibility of the device accuracy of the non-invasive ultrasound blood pressure sensor in comparison to a sphygmomanometer on 90 participants in consulting room on orthostatic hypotension participants.

Device comparison to standard monitoring (A-line)3 years

Clinical feasibility of the ultrasound blood pressure sensor in comparison to an arterial line in the catheterization laboratory on 40 participants.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UCSD

🇺🇸

La Jolla, California, United States

© Copyright 2025. All Rights Reserved by MedPath